Table 3 Description of the concurrent subsample in terms of gender, age, and frailty according to their classification in the CFS and RISC scales
From: Validation of an electronic frailty index with electronic health records: eFRAGICAP index
Clinical Frailty Scale (CFS) | Risk Instrument for Screening in the Community (RISC) | |||||
|---|---|---|---|---|---|---|
Non-Frail (CFS ≤4) (N = 269) | Frail (CFS > 4) (N = 64) | p-value | Low level (N = 254) | Medium-high level (N = 79) | p-value | |
Gender | 0.01 | 0.88 | ||||
Female | 146 (76.0%) | 46 (24.0%) | 147 (76.6%) | 45 (23.4%) | ||
Male | 123 (87.2%) | 18 (12.8%) | 107 (75.9%) | 34 (24.1%) | ||
Age | 79.0 (5.5) | 84.1 (5.9) | < 0.001 | 79.1 (5.5) | 82.7 (6.3) | < 0.001 |
Frailty categories | < 0.001 | < 0.001 | ||||
Fit | 41 (97.6%) | 1 (2.4%) | 40 (95.2%) | 2 (4.8%) | ||
Mild | 99 (94.3%) | 6 (5.7%) | 98 (93.3%) | 7 (6.7%) | ||
Moderate | 98 (74.2%) | 34 (25.8%) | 103 (78.0%) | 29 (22.0%) | ||
Severe | 31 (57.4%) | 23 (42.6%) | 13 (24.1%) | 41 (75.9%) | ||
eFRAGICAP score | 0.239 (0.11) | 0.359 (0.11) | < 0.001 | 0.227 (0.10) | 0.375 (0.12) | < 0.001 |